Active, not recruiting
Combination of Vebreltinib and Osimertinib in Patients with EGFR 21 L858R Mutation Advanced NSCLC
NCT06827145
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Cancer insititue and Hospital of CHINESE ACADEMY OF MEDICAL SCIENCE Beijing, China